…morbidity and mortality burden. Because patients with PAH have very variable responses to standard therapies which is difficult to predict, as well as monitoring the effectiveness of such therapies. The…

…morbidity and mortality burden. Because patients with PAH have very variable responses to standard therapies which is difficult to predict, as well as monitoring the effectiveness of such therapies. The…
The technology relates to miRNA biomarkers to identify patients with pulmonary hypertension (PH), and sub-classify patients with pulmonary arterial hypertension (PAH) and chronic thromembolic PH (CTEPH). Proposed use The present…
…in longevity and controlled drug release, preventing premature dispersal. Its robust performance in physiological conditions and its ability to facilitate a slow, regulated release make it a compelling choice for…
…Proposed use The proposed ultrasound imaging technology advances clinical ultrasound from 2D to more sophisticated 3D/4D imaging. It provides an economical solution for ultrasound imaging manufacturers, enabling the adoption of…
…bacteria to fluoroquinolone antibiotics or as a combination therapy with a fluoroquinolone antibiotic to treat a bacterial infection. Technology overview This invention identifies novel compounds to tackle antimicrobial resistance (AMR)….
…the cost of anode production. Anodes produced are compatible with both lithium-ion and sodium-ion batteries. Anodes has fast-charging capabilities, which is suitable to use in sodium-ion batteries. Anodes has high…
…of this activity to maximise patient outcomes, hence this represents a significant market. Technology overview The present filter system is composed of a matrix embedded with human serum albumin, desferrioxamine…
…with current interventions. Examples include populations of disease vectors, agricultural pests, or undesired invasive species. The types of pest species targetable may include, but is not limited to, insects, other…
…is being developed as an ‘off-the-shelf’ option, without the need for genetic engineering, that can enhance the modularity of iNKT cells and thus their anti-tumour activity. Technology overview iNKT cell…
…liquid or lyophilised form (commercial formulations: cryogenic storage at –70 °C/–20 °C). Simple one-pot, scalable manufacturing; biocompatible, non-toxic; FDA-approved compositions. The low-cost solution, and versatile applications for vaccines and targeted…
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Aenean nec venenatis arcu. In fermentum non tellus nec vulputate. Integer accumsan, nunc sit amet porta commodo, diam sapien feugiat purus, at imperdiet arcu nisi quis dui. Etiam vel nisl sem. Proin felis nisl, fringilla eu eros ac, sodales pellentesque sem.